NCT00962624 - Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2012

Conditions

Meningococcal Meningitis, Serogroup AMeningococcal Meningitis, Serogroup BMeningococcal Meningitis, Serogroup CMeningococcal Meningitis, Serogroup YMeningococcal Meningitis, Serogroup W

Interventions

DRUG

meningococcal B vaccine & meningococcal ACYW conjugate vaccine

Meningococcal B vaccine will be administered at 0, 2 and 6 months and a single dose of meningococcal ACYW vaccine will be administered at 0 months, concomitantly with the first dose of the meningococcal B vaccine.

Trial Locations (1)

M13 9WZ

Manchester Medical Microbiology Partnership, Manchester